Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.100-0.140 for the period, compared to the consensus estimate of 0.130. The company issued revenue guidance of $300.0 million-$310.0 million, compared to the consensus revenue estimate of $319.1 million. Cross Country Healthcare also updated its Q4 guidance to $0.10-$0.14 EPS.
Wall Street Analysts Forecast Growth
Several research firms recently commented on CCRN. Barrington Research reduced their target price on Cross Country Healthcare from $21.00 to $19.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Truist Financial lowered their target price on shares of Cross Country Healthcare from $17.00 to $15.00 and set a “hold” rating on the stock in a research note on Monday, October 21st. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Cross Country Healthcare presently has a consensus rating of “Hold” and a consensus price target of $18.75.
View Our Latest Stock Report on CCRN
Cross Country Healthcare Stock Up 6.1 %
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Stories
- Five stocks we like better than Cross Country Healthcare
- Low PE Growth Stocks: Unlocking Investment Opportunities
- What a Trump Win Looks Like for the Market Now and Into 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Investing in Construction Stocks
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.